Brown A F, McKinnon D, Chu K
Department of Emergency Medicine, Royal Brisbane Hospital, QLD, Australia.
J Allergy Clin Immunol. 2001 Nov;108(5):861-6. doi: 10.1067/mai.2001.119028.
There are few data on the incidence, clinical features, and management of patients with acute anaphylaxis presenting to the emergency department. We investigated all presentations to one department during the course of a year to improve current awareness of this medical emergency.
The purpose of the study was to describe the clinical features, management, and outcome of anaphylaxis presentations to a single Australian adult emergency department in a single year, 1998-1999.
This was a retrospective, case-based study of adult patients (>or=13 years of age) attending a single emergency department in Brisbane, Australia, during the year 1998-1999. The medical records of 304 patients satisfying the relevant discharge diagnostic codes were studied. We determined incidence, sex ratio, age, clinical features, management, disposal, asthma prevalence, and causes in patients presenting with acute allergic reactions and anaphylaxis.
In all, 162 emergency department patients with acute allergic reactions and 142 emergency department patients with anaphylaxis, including 60 whose anaphylaxis was severe, were seen during the year, for an anaphylaxis presentation incidence of 1 in 439. One patient died; this gave a case fatality rate of 0.70%. Cutaneous features were present in 94% of the patients with anaphylaxis. Of those with severe anaphylaxis, 35% had dizziness/syncope before hospital presentation, 25% laryngeal edema, and 21.7% systolic hypotension on hospital presentation. A cause was recognized in 73% of the anaphylaxis cases; most commonly, the causative agent was a drug, insect venom, or food. Adrenaline was used in 57% of the severe cases before hospital presentation or in the hospital. The emergency department alone definitively cared for 94% of all patients, though only 43% severe anaphylaxis cases were referred for follow-up.
The emergency department anaphylaxis presentation incidence of 1 in 439 cases is greater than previously recognized, though death remains rare. In three fourths of cases, a precipitant was identified, a fact that emphasizes the need for a detailed initial history. Definitive management in the emergency department alone is possible in most cases, provided that the appropriate use of adrenaline and the need for allergy clinic follow-up are appreciated.
关于急诊科急性过敏反应患者的发病率、临床特征及治疗的数据较少。我们对某科室一年中的所有就诊病例进行了调查,以提高对这一医疗急症的当前认知。
本研究的目的是描述1998 - 1999年澳大利亚一家成人急诊科过敏反应就诊病例的临床特征、治疗及转归情况。
这是一项基于病例的回顾性研究,研究对象为1998 - 1999年期间在澳大利亚布里斯班一家急诊科就诊的成年患者(年龄≥13岁)。研究了304例符合相关出院诊断编码患者的病历。我们确定了急性过敏反应和过敏反应患者的发病率、性别比、年龄、临床特征、治疗、处置、哮喘患病率及病因。
该年共诊治162例急诊科急性过敏反应患者和142例急诊科过敏反应患者,其中60例为严重过敏反应,过敏反应就诊发病率为1/439。1例患者死亡,病死率为0.70%。94%的过敏反应患者有皮肤表现。在严重过敏反应患者中,35%在入院前有头晕/晕厥,25%有喉头水肿,21.7%入院时收缩压降低。73%的过敏反应病例可明确病因;最常见的致病因素是药物、昆虫毒液或食物。57%的严重病例在入院前或入院时使用了肾上腺素。仅急诊科就确诊并治疗了所有患者中的94%,不过只有43%的严重过敏反应病例被转诊进行随访。
急诊科过敏反应就诊发病率为1/439,高于先前认知,尽管死亡仍然罕见。四分之三的病例可确定诱发因素,这一事实强调了详细询问初始病史的必要性。在大多数情况下,仅在急诊科进行明确治疗是可行的,前提是要正确使用肾上腺素并认识到需要过敏门诊随访。